NCT01858090

Brief Summary

In this prospective, randomized, double-blind, controlled study, the aim was to compare the effect of adding fentanyl (10 µg) or sufentanil (2.5 µg) to levobupivacaine (2.2±0.2 ml 0.5%) on the intraoperative anesthesia quality, block characteristics, the side effects on the newborn and mother, the duration of postoperative analgesia, and surgeon satisfaction score.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
93

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jan 2009

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2010

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2013

Completed
19 days until next milestone

First Posted

Study publicly available on registry

May 21, 2013

Completed
Last Updated

May 21, 2013

Status Verified

May 1, 2013

Enrollment Period

9 months

First QC Date

May 2, 2013

Last Update Submit

May 20, 2013

Conditions

Keywords

spinal anesthesiacaesarean sectionlocal anestheticslevobupivacainesufentanilfentanylabove 18 years of agepregnant womenmultiparousnulliparous

Outcome Measures

Primary Outcomes (1)

  • Comparison of the effect of adding fentanyl or sufentanil to levobupivacaine (2.2±0.2 ml 0.5%) on intraoperative anesthesia quality block characteristics side effects on newborn and mother,duration of postoperative analgesia,surgeon satisfaction score

    during caesarean section and postoperative first 24 hours

Other Outcomes (1)

  • The time of first analgesic requirement

    Postoperative first 24 hours

Study Arms (3)

Control Group

PLACEBO COMPARATOR

Control Group, Group C: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ Serum saline

Drug: Control Group ChirocaineDrug: EphedrineDrug: Atropine sulfateDrug: PropofolDrug: MetoclopramideDrug: DiphenhydramineDrug: pethidine hydrochlorideDrug: Diclofenac sodium

Group Fentanyl

ACTIVE COMPARATOR

Group Fentanyl, Group F: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml+fentanyl (10 µg)

Drug: Group FentanylDrug: EphedrineDrug: Atropine sulfateDrug: PropofolDrug: MetoclopramideDrug: DiphenhydramineDrug: pethidine hydrochlorideDrug: Diclofenac sodium

Group sufentanil

ACTIVE COMPARATOR

Group sufentanil, Group S: spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ sufentanil (2.5 µg)

Drug: Group sufentanilDrug: EphedrineDrug: Atropine sulfateDrug: PropofolDrug: MetoclopramideDrug: DiphenhydramineDrug: pethidine hydrochlorideDrug: Diclofenac sodium

Interventions

Control group: Spinal anesthesia with levobupivacaine+Serum Physiologic %0.9 (Total volume 3 mL)

Also known as: Chirocaine, Chirocaine®, Abbott Laboratories, Ireland, 113/13, 16.12.2002, Serum Physiologic %0.9, Serum Fizyolojik %0.9 10 ml Ampul, Adeka İlac, 8699587751799
Control Group
Also known as: Fentanyl®, Johnson&Johnson, USA, 110/53, 01.08.2001
Group Fentanyl
Also known as: Sufenta®, Johnson&Johnson, USA, 108/26, 15.08.2000
Group sufentanil

If systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to \<100 mmHg, fluid loading and ephedrine (5 mg) were administered.

Also known as: EFEDRİN HİDROKLORÜR AMPUL 0.05 g, 1 ml, 30.06.1999 - 192/42, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBUL
Control GroupGroup FentanylGroup sufentanil

A decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered

Also known as: ATROPİN SÜLFAT AMPUL 1/4 mg, 1 ml, 30.06.1999 - 192/9, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBUL
Control GroupGroup FentanylGroup sufentanil

Intravenous propofol (up to 0.5 mg/kg) was administered if patients had discomfort

Also known as: Propofol Ampul, Abbott Laboratories, USA, 23.12.1998 - 105/37
Control GroupGroup FentanylGroup sufentanil

Metoclopramide (10 mg IV) was administered for nausea

Also known as: Metpamid Ampul, Üretici Firma:YENI ILAC VE HAMMADDELERI SANAYI VE TICARET A.S., Esenyurt/ISTANBUL, 300188-1 BR, Etken Madde(ler):Metoklopramid HCI 10 mg/2 ml
Control GroupGroup FentanylGroup sufentanil

for severe pruritus

Also known as: Benison Ampul, Osel İlaç, 8699788750300
Control GroupGroup FentanylGroup sufentanil

pethidine hydrochloride (50 mg IM) was administered as the first analgesic postoperatively

Also known as: Aldolan ampul, Liba Laboratuarları A.Ş., 20.12.1985 - 86/29, Gerot Pharmazeutika GmbH, Arnethgasse 3, 1171 Viyana, Avusturya
Control GroupGroup FentanylGroup sufentanil

as additional analgesic among cases in which VAS\>3(Postoperatively)

Also known as: Diclomec Ampul 75 mg/ 3 ml, Mecom Saglik Urunleri San. ve Tic. A.S, 8699633759366
Control GroupGroup FentanylGroup sufentanil

Eligibility Criteria

Age19 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women
  • above 18 years of age
  • gestational pregnancy age ≥ 36 weeks
  • height ≥ 155 cm
  • weight ≤110 kg
  • fetal weight ≥ 2500 g)
  • American Society of Anesthesiologists (ASA) Physical Status of I to II
  • elective caesarean section surgeries were enrolled.

You may not qualify if:

  • Local anesthetic allergy
  • history of hypersensitivity and anaphylactic reactions
  • emergency surgery
  • preeclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baskent University School of Medicine Adana Teaching and Research Hospital

Adana, 01250, Turkey (Türkiye)

Location

Related Publications (2)

  • Karaman S, Kocabas S, Uyar M, Hayzaran S, Firat V. The effects of sufentanil or morphine added to hyperbaric bupivacaine in spinal anaesthesia for caesarean section. Eur J Anaesthesiol. 2006 Apr;23(4):285-91. doi: 10.1017/S0265021505001869. Epub 2006 Jan 27.

    PMID: 16438758BACKGROUND
  • Bozdogan Ozyilkan N, Kocum A, Sener M, Caliskan E, Tarim E, Ergenoglu P, Aribogan A. Comparison of intrathecal levobupivacaine combined with sufentanil, fentanyl, or placebo for elective caesarean section: a prospective, randomized, double-blind, controlled study. Curr Ther Res Clin Exp. 2013 Dec;75:64-70. doi: 10.1016/j.curtheres.2013.09.003.

MeSH Terms

Interventions

LevobupivacaineFentanylSufentanilEphedrineAtropinePropofolMetoclopramideDiphenhydramineMeperidineDiclofenac

Intervention Hierarchy (Ancestors)

BupivacaineAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPropanolaminesAmino AlcoholsAlcoholsPropanolsPhenethylaminesEthylaminesAtropine DerivativesTropanesAzabicyclo CompoundsAza CompoundsBelladonna AlkaloidsSolanaceous AlkaloidsAlkaloidsBridged Bicyclo Compounds, HeterocyclicHeterocyclic Compounds, Bridged-RingPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsBenzamidespara-AminobenzoatesAminobenzoatesBenzoatesAcids, CarbocyclicCarboxylic AcidsChlorobenzoatesHydroxybenzoate EthersHydroxybenzoatesHydroxy AcidsPhenyl EthersBenzhydryl CompoundsIsonipecotic AcidsAcids, HeterocyclicPhenylacetates

Study Officials

  • Anis Aribogan, Prof., MD

    Baskent University School of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 2, 2013

First Posted

May 21, 2013

Study Start

January 1, 2009

Primary Completion

October 1, 2009

Study Completion

January 1, 2010

Last Updated

May 21, 2013

Record last verified: 2013-05

Locations